{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:59:15Z","timestamp":1790632755581,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.bonr.2018.07.002","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T00:26:20Z","timestamp":1532478380000},"page":"93-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Vitamin D and kidney disease"],"prefix":"10.1016","volume":"9","author":[{"given":"Lisa","family":"Keung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzana","family":"Perwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bonr.2018.07.002_bb0005","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1172\/JCI111147","article-title":"Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis","volume":"72","author":"Adams","year":"1983","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bonr.2018.07.002_bb0010","doi-asserted-by":"crossref","first-page":"466","DOI":"10.5414\/CNP75466","article-title":"Idiopathic hypercalcemia in infants with renal dysplasia","volume":"75","author":"Al","year":"2011","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.bonr.2018.07.002_bb0025","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0960-0760(92)90334-F","article-title":"Characterization and regulation of the vitamin D hydroxylases","volume":"43","author":"Armbrecht","year":"1992","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bonr.2018.07.002_bb0030","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/ndt\/gfs299","article-title":"The consequences of chronic kidney disease on bone metabolism and growth in children","volume":"27","author":"Bacchetta","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bonr.2018.07.002_bb0035","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.M210490200","article-title":"The autosomal dominant hypophosphatemic rickets R176Q mutation in FGF23 resists proteolytic cleavage and enhances in vivo biological potency","volume":"278","author":"Bai","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bonr.2018.07.002_bb0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11914-012-0098-z","article-title":"Vitamin D and bone","volume":"10","author":"Bikle","year":"2012","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bonr.2018.07.002_bb0045","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI112609","article-title":"1,25-Dihydroxyvitamin D3 production by human keratinocytes","volume":"78","author":"Bikle","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bonr.2018.07.002_bb0050","first-page":"519","article-title":"Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study","volume":"58","author":"Budoff","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bonr.2018.07.002_bb0055","doi-asserted-by":"crossref","first-page":"7774","DOI":"10.1016\/S0021-9258(20)89517-9","article-title":"Characterization of human sterol 27-hydroxylase","volume":"266","author":"Cali","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bonr.2018.07.002_bb0060","first-page":"E483","article-title":"Dissociation of phosphaturia and 25(OH)D-1\u03b1-hydroxylase trophism using a novel analogue of parathyroid hormone","volume":"262","author":"Carpenter","year":"1992","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bonr.2018.07.002_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02556591","article-title":"The effect of 1,25-dihydroxycholecalciferol on parathyroid hormone secretion by monolayer cultures of bovine parathyroid cells","volume":"38","author":"Chan","year":"1986","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bonr.2018.07.002_bb0070","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1073\/pnas.0402490101","article-title":"Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase","volume":"101","author":"Cheng","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bonr.2018.07.002_bb0075","first-page":"129","article-title":"1-Alpha-oh-cholecalciferol (1-alpha-OHD3) and low phosphate diet in predialysis chronic renal failure: effects on renal function and on secondary hyperparathyroidism","volume":"6","author":"Coen","year":"1984","journal-title":"Acta Vitaminol. Enzymol."},{"key":"10.1016\/j.bonr.2018.07.002_bb0080","first-page":"375","article-title":"Treatment of secondary hyperparathyroidism of predialysis chronic renal failure with low doses of 1,25(OH)2D3: humoral and histomorphometric results","volume":"12","author":"Coen","year":"1986","journal-title":"Miner. Electrolyte Metab."},{"key":"10.1016\/j.bonr.2018.07.002_bb0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000057611","article-title":"Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH","volume":"91","author":"Coen","year":"2002","journal-title":"Nephron"},{"issue":"1","key":"10.1016\/j.bonr.2018.07.002_bb0090","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2015.290","article-title":"Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production","volume":"89","author":"David","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.bonr.2018.07.002_bb0095","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1172\/JCI114022","article-title":"Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D","volume":"83","author":"Delmez","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bonr.2018.07.002_bb0100","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jc.2012-4188","article-title":"Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease","volume":"98","author":"Denburg","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2018.07.002_bb0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ki.1996.283","article-title":"1,25-Dihydroxyvitamin D3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats","volume":"50","author":"Denda","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.bonr.2018.07.002_bb0110","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/ndt\/gfu190","article-title":"Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD","volume":"29","author":"Di Marco","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bonr.2018.07.002_bb0115","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ki.2013.271","article-title":"Early chronic kidney disease-mineral bone disorder stimulates vascular calcification","volume":"85","author":"Fang","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.bonr.2018.07.002_bb0120","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bonr.2018.07.002_bb0125","series-title":"Osteoporosis","first-page":"205","article-title":"Vitamin D: metabolism and action","author":"Feldman","year":"1996"},{"key":"10.1016\/j.bonr.2018.07.002_bb0130","first-page":"1961","article-title":"Cloning of human 25-hydroxyvitamin D-1\u03b1-hydroxylase and mutations causing vitamin D-dependent rickets type 1","volume":"11","author":"Fu","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bonr.2018.07.002_bb0135","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1089\/dna.1997.16.1499","article-title":"Complete structure of the human gene for the vitamin D 1\u03b1-hydroxylase, P450c1\u03b1","volume":"16","author":"Fu","year":"1997","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.bonr.2018.07.002_bb0140","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1994.380","article-title":"Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy","volume":"46","author":"Goodman","year":"1994","journal-title":"Kidney Int."},{"key":"10.1016\/j.bonr.2018.07.002_bb0145","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1515\/jpem-2012-0286","article-title":"Parathyroid hormone-independent hypercalcemia in an infant with renal dysplasia: possible role of PTHrP","volume":"26","author":"Grob","year":"2013","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2018.07.002_bb0150","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bonr.2018.07.002_bb0155","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bonr.2018.07.002_bb0160","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","article-title":"Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure","volume":"310","author":"Hamdy","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.bonr.2018.07.002_bb0165","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.2010.313","article-title":"Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease","volume":"78","author":"Hasegawa","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.bonr.2018.07.002_bb0170","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/S0021-9258(17)30132-1","article-title":"Regulation of the hydroxylation of 25-hydroxyvitamin D3 in vivo and in primary cultures of chick kidney cells","volume":"254","author":"Henry","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bonr.2018.07.002_bb0175","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1016\/S0021-9258(18)43337-6","article-title":"Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3","volume":"256","author":"Howard","year":"1981","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bonr.2018.07.002_bb0180","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.bonr.2018.07.002_bb0185","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bonr.2018.07.002_bb0015","first-page":"S1","article-title":"Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","author":"KDIGO","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.bonr.2018.07.002_bb0020","first-page":"S1","article-title":"Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","author":"KDIGO","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.bonr.2018.07.002_bb0190","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40697-015-0052-y","article-title":"PTHrP-related hypercalcaemia in infancy and congenital anomalies of the kidney and urinary tract (CAKUT)","volume":"2","author":"Kodous","year":"2015","journal-title":"Can. J. Kidney Health Dis."},{"key":"10.1016\/j.bonr.2018.07.002_bb0195","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2003-1768","article-title":"Transgenic mice expressing Fibroblast Growth Factor 23 under the control of the \u03b11(I) collagen promoter exhibit growth retardation, osteomalacia and disturbed phosphate homeostasis","volume":"145","author":"Larsson","year":"2004","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.bonr.2018.07.002_bb0200","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/ki.2012.322","article-title":"Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet","volume":"82","author":"Lau","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.bonr.2018.07.002_bb0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.bonr.2018.07.002_bb0210","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/ATVBAHA.109.196576","article-title":"Vitamin D receptor activators induce an anticalcific paracrine program in macrophages: requirement of osteopontin","volume":"30","author":"Li","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bonr.2018.07.002_bb0215","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1681\/ASN.2007080902","article-title":"Vitamin D receptor activators can protect against vascular calcification","volume":"19","author":"Mathew","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bonr.2018.07.002_bb0220","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1681\/ASN.V3121938","article-title":"Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital","volume":"3","author":"Mathias","year":"1993","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bonr.2018.07.002_bb0225","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000186151","article-title":"Osteocalcin, iPTH, alkaline phosphatase and hand x-ray scores as predictive indices of histomorphometric parameters in renal osteodystrophy","volume":"56","author":"Mazzaferro","year":"1990","journal-title":"Nephron"},{"key":"10.1016\/j.bonr.2018.07.002_bb0230","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.bonr.2018.07.002_bb0235","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1210\/endo.140.5.6691","article-title":"Positive and negative regulations of the renal 25-hydroxyvitamin D3 1\u03b1-hydroxylase gene by parathyroid hormone, calcitonin, and 1\u03b1,25(OH)2D3 in intact animals","volume":"140","author":"Murayama","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.bonr.2018.07.002_bb0240","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","article-title":"Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease","volume":"45","author":"Pereira","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2018.07.002_bb0245","doi-asserted-by":"crossref","first-page":"F1577","DOI":"10.1152\/ajprenal.00463.2006","article-title":"Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro","volume":"293","author":"Perwad","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bonr.2018.07.002_bb0250","series-title":"Pediatric Bone - Biology and Diseases","first-page":"679","article-title":"Rickets due to hereditary abnormalities of vitamin D synthesis or action","author":"Portale","year":"2011"},{"key":"10.1016\/j.bonr.2018.07.002_bb0255","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2215\/CJN.05840513","article-title":"Disordered FGF23 and mineral metabolism in children with CKD","volume":"9","author":"Portale","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bonr.2018.07.002_bb0260","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1523-1755.2005.00402.x","article-title":"Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes","volume":"68","author":"Qunibi","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.bonr.2018.07.002_bb0265","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/beta-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2018.07.002_bb0270","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/sj.ki.5002696","article-title":"Exploring the biology of vascular calcification in chronic kidney disease: what's circulating?","volume":"73","author":"Schoppet","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.bonr.2018.07.002_bb0275","first-page":"250","article-title":"Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency","volume":"44","author":"Shigematsu","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bonr.2018.07.002_bb0280","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bonr.2018.07.002_bb0285","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1681\/ASN.2006121397","article-title":"Mineral metabolism and vascular damage in children on dialysis","volume":"18","author":"Shroff","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bonr.2018.07.002_bb0290","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1093\/ndt\/gfn226","article-title":"The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis","volume":"23","author":"Shroff","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bonr.2018.07.002_bb0295","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1210\/endo-122-6-2387","article-title":"Effect of 1,25-dihydroxyvitamin D3 on phospholipid metabolism in cultured bovine parathyroid cells","volume":"122","author":"Sugimoto","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.bonr.2018.07.002_bb0300","first-page":"E168","article-title":"Rat renal 25-hydroxyvitamin D3 1- and 24-hydroxylases: their in vivo regulation","volume":"246","author":"Tanaka","year":"1984","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bonr.2018.07.002_bb0305","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2215\/CJN.05940611","article-title":"Early skeletal and biochemical alterations in pediatric chronic kidney disease","volume":"7","author":"Wesseling-Perry","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bonr.2018.07.002_bb0310","series-title":"Mineral Metabolism: An Advanced Treatise. 1","first-page":"1","article-title":"Chemical composition of the body","author":"Widdowson","year":"1964"},{"key":"10.1016\/j.bonr.2018.07.002_bb0315","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2016.11.012","article-title":"Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and Klotho","volume":"100","author":"Yamada","year":"2017","journal-title":"Bone"}],"updated-by":[{"DOI":"10.1016\/j.bonr.2021.101084","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000}}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187218300433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187218300433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:19:09Z","timestamp":1762445949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187218300433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":63,"alternative-id":["S2352187218300433"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2018.07.002","relation":{},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D and kidney disease","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2018.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}